Status:
COMPLETED
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
Lead Sponsor:
Pfizer
Collaborating Sponsors:
University of Connecticut School of Pharmacy and Hartford Hospital
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints ...
Detailed Description
This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints ...
Eligibility Criteria
Inclusion
- Randomized controlled clinical trials of treatments for moderate-to-severe plaque psoriasis.
- Trials had to evaluate at least one of the following: Physician's Global Assessment (PGA), Dermatology Life Quality Index (DLQI) and/or the Short-Form 36 (SF-36).
Exclusion
- Observational studies
- Trials that did not report the Physician's Global Assessment (PGA),
- Dermatology Life Quality Index (DLQI) or the Short-Form 36 (SF-36).
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01425138
Start Date
June 1 2009
End Date
June 1 2011
Last Update
December 3 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.